Stockreport

Data from Newron's study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS) [Yahoo! Fina...

Supernus Pharmaceuticals, Inc.  (SUPN) 
Last supernus pharmaceuticals, inc. earnings: 2/25 04:40 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.supernus.com
PDF Presentation of study design for potentially pivotal phase III trial for TRS patients Information on potentially pivotal study 008A in non-TRS patients presented, wit [Read more]